In 2012, blood, skin and soft tissue infections caused by clindamycin resistant Streptococcus pyogenes (group A streptococcus; GAS) appeared to be increasing in the Helsinki metropolitan area. We compared monthly percentages of clindamycin resistant isolates in the area between 2012 and 2013, with those in 2010 and 2011. Resistance frequency in terms of patient age was also studied. We reviewed the medical records of bacteraemic cases in 2012 and 2013 and linked the data to emm types. To inform on the emm distribution among GAS isolated from skin and soft tissue infections during the epidemic, GAS isolates of one month (March 2013) were emm typed. For GAS blood, skin, and soft tissue isolates taken together, the proportions of clindamycin r...
BACKGROUND: Group A Streptococcus (GAS) causes human diseases ranging in severity from uncomplicated...
Abstract Macrolides are often used to treat group A strepto-coccus (GAS) infections, but their resis...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
In 2012, blood, skin and soft tissue infections caused by clindamycin resistant Streptococcus pyogen...
The incidence of invasive group A streptococcal (GAS) infections has shown a fluctuating but increas...
Objectives. Surveillance of antimicrobial resistance and global dissemination of clones with specifi...
Objectives. Surveillance of antimicrobial resistance and global dissemination of clones with specifi...
Objectives. Surveillance of antimicrobial resistance and global dissemination of clones with specifi...
Väitöskirja, liitteenä alkuperäisartikkelit (verkkoversiossa ei alkuperäisartikkeleita
Macrolides are often used to treat group A streptococcus (GAS) infections, but their resistance rate...
ABSTRACTAmong a total of 101 isolates from the first systematic multicentre surveillance effort conc...
Macrolides are often used to treat group A streptococcus (GAS) infections, but their resistance rate...
Publisher's version (útgefin grein)Resistance to macrolide antibiotics is a global concern in the tr...
Macrolides are often used to treat group A streptococcus (GAS) infections, but their resistance rate...
BACKGROUND: Group A Streptococcus (GAS) causes human diseases ranging in severity from uncomplicated...
BACKGROUND: Group A Streptococcus (GAS) causes human diseases ranging in severity from uncomplicated...
Abstract Macrolides are often used to treat group A strepto-coccus (GAS) infections, but their resis...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
In 2012, blood, skin and soft tissue infections caused by clindamycin resistant Streptococcus pyogen...
The incidence of invasive group A streptococcal (GAS) infections has shown a fluctuating but increas...
Objectives. Surveillance of antimicrobial resistance and global dissemination of clones with specifi...
Objectives. Surveillance of antimicrobial resistance and global dissemination of clones with specifi...
Objectives. Surveillance of antimicrobial resistance and global dissemination of clones with specifi...
Väitöskirja, liitteenä alkuperäisartikkelit (verkkoversiossa ei alkuperäisartikkeleita
Macrolides are often used to treat group A streptococcus (GAS) infections, but their resistance rate...
ABSTRACTAmong a total of 101 isolates from the first systematic multicentre surveillance effort conc...
Macrolides are often used to treat group A streptococcus (GAS) infections, but their resistance rate...
Publisher's version (útgefin grein)Resistance to macrolide antibiotics is a global concern in the tr...
Macrolides are often used to treat group A streptococcus (GAS) infections, but their resistance rate...
BACKGROUND: Group A Streptococcus (GAS) causes human diseases ranging in severity from uncomplicated...
BACKGROUND: Group A Streptococcus (GAS) causes human diseases ranging in severity from uncomplicated...
Abstract Macrolides are often used to treat group A strepto-coccus (GAS) infections, but their resis...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...